We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current NVRO market cap is 151.76M. The company's latest EPS is USD -2.4609 and P/E is -1.65.
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 103.86M | 116.18M | 101.9M | 104.16M | 96.91M |
Operating Income | -25.56M | -11.79M | -35.83M | -25.12M | -13.87M |
Net Income | -23.48M | -8.98M | -25.41M | -19.58M | -15.34M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 390.26M | 362.05M | 386.91M | 511.37M | 425.17M |
Operating Income | -96.48M | -62.85M | -110.93M | 6.16M | -99.31M |
Net Income | -103.69M | -83.07M | -131.36M | 3M | -92.21M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 561.58M | 635.71M | 596.05M | 603.34M | 595.65M |
Total Liabilities | 275.92M | 342.57M | 317.51M | 329.08M | 322.01M |
Total Equity | 285.67M | 293.15M | 278.54M | 274.25M | 273.64M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 469.65M | 789.43M | 574.54M | 602.41M | 635.71M |
Total Liabilities | 253.29M | 400.97M | 270.93M | 278.53M | 342.57M |
Total Equity | 216.35M | 388.46M | 303.62M | 323.88M | 293.15M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -49.91M | -58.83M | -32.66M | -40.77M | -38.03M |
Investing | -6.09M | -7.2M | 25.32M | 15.79M | 9.36M |
Financing | 836k | 49.53M | -6.48M | -4.48M | -4.84M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -50.23M | 1.19M | -41.88M | 24.68M | -58.83M |
Investing | 32.33M | -369.87M | 201.72M | 64.29M | -7.2M |
Financing | 32.09M | 346.91M | -169.38M | -2.46M | 49.53M |
Market Cap | 151.76M |
Price to Earnings Ratio | -1.65 |
Price to Sales Ratio | 0.36 |
Price to Cash Ratio | 1.46 |
Price to Book Ratio | 0.52 |
Dividend Yield | - |
Shares Outstanding | 37.47M |
Average Volume (1 week) | 396.15k |
Average Volume (1 Month) | 421.14k |
52 Week Change | -81.30% |
52 Week High | 22.525 |
52 Week Low | 3.9237 |
Spread (Intraday) | 0.02 (0.49%) |
Company Name | Nevro Corp |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://www.nevro.com |
Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions